FDA.reportPublic FDA data

bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]

RxCUI
1049299
RxNorm name
bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]
Display name
bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]
Full name
bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
978286be-3707-48c3-a1ee-fa6517bfdf50Bismusal 1.75 % Oral Suspension [PSN] · bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal] [SBD] · Bismusal 1.75 % Oral Suspension [SY] · Bismusal 17.5 MG/ML Oral Suspension [SY]410BISMUSAL SUSPENSION20171011